clinical trial · NCT05670951
Efficacy and Safety of ELGN-2112 on Intestinal Malabsorption in Preterm Infants
Intestinal MalabsorptionELGN-2112Placebo
brief summary
The study will evaluate the effect of ELGN-2112 on intestinal malabsorption in preterm infants.
started
Feb 27, 2025
primary completion
Nov 1, 2027
completion
May 1, 2029
last updated
Jan 23, 2026
official title
A Multi-center, Double-Blind, Randomized, Two-Arm, Parallel-Group, Placebo Controlled Study to Assess the Efficacy and Safety of ELGN-2112 on Intestinal Malabsorption in Preterm Infants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol